| Identification | Back Directory | [Name]
Ripisartan | [CAS]
148504-51-2 | [Synonyms]
UP 269-6
Ripisartan
5-Methyl-7-n-propyl-8-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-(1,2,4)-triazolo(1,5-c)pyrimidin-2(3H)-one
[1,2,4]Triazolo[1,5-c]pyrimidin-2(3H)-one, 5-methyl-7-propyl-8-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | [Molecular Formula]
C23H22N8O | [MDL Number]
MFCD00917221 | [MOL File]
148504-51-2.mol | [Molecular Weight]
426.47 |
| Hazard Information | Back Directory | [Uses]
Ripisartan (UP-2696) is an angiotensin II receptor antagonist. Ripisartan is orally available. Ripisartan binds to angiotensin II receptors, dilates blood vessels, and lowers blood pressure[1]. | [IC 50]
AT2 Receptor | [References]
[1] Virone-Oddos A, et al. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Br J Pharmacol. 1997 Feb;120(3):488-94. DOI:10.1038/sj.bjp.0700897 |
|
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|